You are here

Lexaria's DehydraTECH Overcomes Key Hurdles for Cannabis Extracts -- CFN Media

SEATTLE, June 26, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article covering Lexaria Bioscience Inc. (CSE:LXX) (LXX.CN) (CNSX:LXX) (OTCQX:LXRP). The company addresses the shortcomings of precise dosing across a wide range of delivery systems with its DehydraTECH™ drug delivery platform. By combining cannabinoids with fatty acid oil, applying food carrier particles, and performing a dehydration procedure, the technology masks the bitter and earthy taste of cannabis oil and ensures quick and effective transportation into the bloodstream without degradation in the stomach or liver. Lexaria’s technology now has over 40 patents pending and four patents already granted in the US.

Cannabis oils and extracts have become tremendously popular following the legalization of medical and recreational cannabis across a growing number of jurisdictions. In addition to avoiding the health risks of smoking, cannabis oils and extracts enable patients and consumers to access precise dosing across a wide range of delivery systems (e.g. capsules, vape oil, or edibles) for a consistent experience every time.

Masking Poor Taste

The taste of cannabis oils and extracts depends on the process used to extract the cannabinoids from the plant but it’s generally described as earthy and bitter. In fact, new patients and consumers commonly ask how they can mask the taste of the drug. Many people recommend taking cannabis oils and extracts with breath mints or other products, but the process can be inconvenient at best and ineffective at worst.

Lexaria’s DehydraTECH™ technology masks the earthy and bitter flavors of cannabis oils and extracts using fatty acids. These fatty acids are believed to block and shunt bound ingredients away from bitter taste receptors, which eliminates the bad taste in products that incorporate the technology. Non-active ingredients can then be added to re-flavor the cannabis oils and extracts to make them more palatable for patients and consumers.

For example, Nuka Enterprises LLC signed a licensing agreement earlier this year for its cannabis-infused line of chocolates and edible products. The company had already been utilizing Lexaria’s technology in its award-winning 1906 brand of chocolates for about two years to mask cannabis flavors and ensure a great taste -- along with the many other benefits of Lexaria’s DehydraTECH™ platform.

Improving Bioavailability

Cannabinoids have poor bioavailability for a couple different reasons: Orally-consumed cannabinoids are largely destroyed by stomach acids, and those that aren’t are broken down and altered by first pass metabolism in the liver. This is why smoking cannabis has a much more immediate effect than orally-consumed cannabis; it avoids first-pass metabolism and is more quickly absorbed into the bloodstream through the lungs.

Lexaria’s DehydraTECH™ technology protects orally-consumed cannabinoids during the stomach transit by co-joining them with lipids. At the same time, the long-chain fatty acids bypass first pass liver metabolism by design, enabling the cannabinoids to remain intact upon delivery to the bloodstream. These two features help increase the bioavailability of cannabinoids and ultimately make them more effective for medical cannabis patients or recreational users, and also allow the edible experience to more closely mimic the smoked experience, for the first time ever.

Management has found that DehydraTECH™ reduces the onset time for cannabis oils and extracts to just 15 to 20 minutes compared to 60 to 120 minutes for traditional oral cannabinoids. At the same time, bio absorption improves by five to 10 times to match that of inhaled cannabinoid delivery mechanisms. These attributes make the technology ideal for medical uses cases where precise dosing and immediate onset are critical.

Lexaria’s technology has been repeatedly evaluated by invivo, invitro and human studies and is currently undergoing additional evaluation by Canada’s National Research Council.

Looking Ahead

Lexaria Bioscience Inc. (OTCQX:LXRP) represents a compelling investment opportunity in the cannabis industry and beyond. With its innovative DehydraTECH™ platform, the company solves many of the key shortcomings of oral cannabinoids and makes cannabinoid products for both medical and recreational consumers a lot more palatable and effective.

For more information, visit the company’s website at

Please follow the link to read the full article:

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur:

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand:

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone:

Disclaimer is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate., a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. received compensation for producing and presenting high quality and sophisticated content on along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation:  


Frank Lane

Tuesday, June 26, 2018 - 08:50